DUSP5 and neoplasm: In fact, we found that some cell lines with extensive methylation of the DUSP5 promoter, such as RKO, feature high DUSP5 expression, likely due to strong ERK pathway activation driven by mutant BRAF. DUSP5 overexpression has been documented in several tumour types and cell lines harboring BRAF mutations13,14.